Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Agios Pharmaceuticals (AGIO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.12 B
According to Agios Pharmaceuticals 's latest financial reports the company's total liabilities are $0.12 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Agios Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | -8.56% |
| 2022-12-31 | $0.13 B | -5.39% |
| 2021-12-31 | $0.14 B | -67.86% |
| 2020-12-31 | $0.45 B | 81.23% |
| 2019-12-31 | $0.25 B | 46.39% |
| 2018-12-31 | $0.17 B | -28.45% |
| 2017-12-31 | $0.23 B | -8.3% |
| 2016-12-31 | $0.26 B | 247.58% |
| 2015-12-31 | $74.94 M | 10.97% |
| 2014-12-31 | $67.53 M | -3.13% |
| 2013-12-31 | $69.72 M | -25.12% |
| 2012-12-31 | $93.11 M | -29.1% |
| 2011-12-31 | $0.13 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 108,713.71% | 🇺🇸 USA |
 Eli Lilly LLY | $51.04 B | 40,380.97% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $57.22 B | 45,280.30% | 🇬🇧 UK |
 Xencor XNCR | $0.28 B | 124.87% | 🇺🇸 USA |
 Exelixis EXEL | $0.67 B | 435.88% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.79 B | 1,326.55% | 🇺🇸 USA |